文献速递免疫规划妇幼与学校卫生

2017-2021年美国孕产妇Tdap与流感疫苗接种率:对未来孕产妇RSV疫苗接种的启示

Maternal Tdap and influenza vaccination uptake 2017-2021 in the United States: Implications for maternal RSV vaccine uptake in the future.
PubMed 文献 · Vaccine · 2023-11-21

基于Optum电子健康记录数据库,分析2017-2021年美国1,021,260次活产分娩的孕产妇Tdap和流感疫苗接种率。Tdap接种率为55.1%,多数在27-32周接种;流感疫苗接种率为33.5%,主要集中于流感高峰月份。

要点

  • 2017-2021年孕产妇Tdap接种率为55.1%,年度间略有波动(2017年56.6%至2021年52.1%)。
  • 64.4%的Tdap接种发生在27-32周,79.5%发生在推荐的27-36周窗口内。
  • 孕产妇流感疫苗接种率为33.5%,73.0%发生在流感高峰月份(10月至1月)。

核心结论

  • 在这项基于电子健康记录的大规模当代分析中,孕期Tdap疫苗接种率与先前发表的估计一致;值得注意的是,大多数接种发生在推荐的27-36周窗口的早期。孕产妇流感疫苗接种率主要与流感活动高峰月份相关,而非与孕周相关。这些研究结果可能对估计未来孕产妇疫苗的潜在接种率和影响具有重要意义。

研究设计与样本

  • 从Optum电子健康记录数据库中选择2017年至2021年间有活产分娩的18-49岁女性患者,利用近期发表的孕周算法估计孕周。

主要发现

  • 2017-2021年间886,660名女性的1,021,260次分娩中,55.1%在孕期接种了Tdap疫苗;疫苗覆盖率逐年略有变化(2017年56.6%;2018年55.2%;2019年55.2%;2020年54.7%;2021年52.1%)。
  • 大多数(64.4%)孕产妇Tdap疫苗接种发生在27-32孕周;79.5%发生在整个推荐的10周疫苗接种窗口(27-36孕周)内。
  • 在流感疫苗接种评估中(n=798,113次分娩;714,841名女性),33.5%的分娩在2017-2021流感观察年内接种了流感疫苗,其中大多数(73.0%)发生在流感高峰活动月份(10月至1月),约四分之一(27.0%)的接种发生在非高峰月份,主要在9月。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Assessment of maternal vaccine coverage is important for understanding and quantifying the impact of currently recommended vaccines as well as modeling the potential impact of future vaccines. However, existing data lack detail regarding uptake according to week of gestational age (wGA). Such granularity is valuable for more accurate estimation of vaccine impact. OBJECTIVE: To summarize contemporary maternal Tdap vaccination uptake, overall, yearly, and by wGA, and maternal influenza vaccination uptake, overall, by influenza observation year, immunization month, and delivery month, in the US. METHODS: Female patients 18-49 years of age with a pregnancy resulting in a live born infant (i.e., delivery) between 2017 and 2021 were selected from the Optum electronic health records (EHRs) database. Recently published gestational age algorithms were utilized to estimate wGA. RESULTS: Of 1,021,260 deliveries among 886,660 women between 2017-2021, 55.1% had Tdap vaccination during pregnancy; vaccine coverage varied slightly by year (2017: 56.6%; 2018: 55.2%; 2019: 55.2%; 2020: 54.7%; 2021: 52.1%). Most (64.4%) maternal Tdap vaccinations occurred 27-32 wGA; 79.5% occurred during the entire 10-week recommended vaccination window (27-36 wGA). In the evaluation of influenza vaccination uptake (n=798,113 deliveries; 714,841 women), 33.5% of deliveries had influenza vaccination during influenza observation years 2017-2021, most (73.0%) of which occurred during influenza peak activity months (October-January) with approximately one-quarter (27.0%) of vaccinations having occurred during the off-peak months, mostly in September. CONCLUSIONS: In this large contemporary analysis of EHR data, uptake of Tdap vaccination during pregnancy was consistent with previously published estimates; notably, most vaccination occurred early in the recommended 27-36 wGA window. Maternal influenza vaccination uptake largely correlated with peak influenza activity months and not gestational age. These study findings may have important implications for estimating the potential uptake and impact of future maternal vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Law AW, Judy J, Atwell JE, et al. Maternal Tdap and influenza vaccination uptake 2017-2021 in the United States: Implications for maternal RSV vaccine uptake in the future. Vaccine. 2023. PMID: 37993354. doi:10.1016/j.vaccine.2023.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。